Title:
PYRIDINE-SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2016/015676
Kind Code:
A1
Abstract:
Disclosed are pharmaceutically acceptable salts of pyridine-substituted 2-aminopyridine derivatives as protein kinase inhibitors, preparation methods, pharmaceutical compositions thereof, and use thereof in treating the protein kinase-related diseases.
Inventors:
GONG FENG (CN)
LI XINLU (CN)
ZHAO RUI (CN)
ZHANG XIQUAN (CN)
XU XINHE (CN)
LIU XIJIE (CN)
XIAO DENGMING (CN)
HAN YONGXIN (CN)
LI XINLU (CN)
ZHAO RUI (CN)
ZHANG XIQUAN (CN)
XU XINHE (CN)
LIU XIJIE (CN)
XIAO DENGMING (CN)
HAN YONGXIN (CN)
Application Number:
PCT/CN2015/085727
Publication Date:
February 04, 2016
Filing Date:
July 31, 2015
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (CN)
CENTAURUS BIOPHARMA CO LTD (CN)
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (CN)
CENTAURUS BIOPHARMA CO LTD (CN)
International Classes:
A61K31/444; C07D401/14; A61K31/496; A61P35/00; C07D213/73
Domestic Patent References:
| WO2006021886A1 | 2006-03-02 |
Foreign References:
| CN104650049A | 2015-05-27 | |||
| CN103965168A | 2014-08-06 |
Other References:
See also references of EP 3176160A4
Attorney, Agent or Firm:
INSIGHT INTELLECTUAL PROPERTY LIMITED (CN)
北京英赛嘉华知识产权代理有限责任公司 (CN)
北京英赛嘉华知识产权代理有限责任公司 (CN)
Download PDF: